NCT02503982View on ClinicalTrials.gov

Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Infection in Solid Organ Transplant Recipients
Interventions
DRUG

prophylactic Valganciclovir

The common practice dose at Schneider Children's Medical Center dosing guidelines of valganciclovir is 17 mg/kg once daily for prophylaxis, with stratified dose reductions for impaired renal function. Max dose was 900 mg.

Trial Locations (1)

Unknown

Schneider childrens medical center of Isreal, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT02503982 - Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients | Biotech Hunter | Biotech Hunter